Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Pollack

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Cancer|May 3, 2017
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomasSeth M Pollack, Qianchuan He, Jennifer H Yearley, et al.
JAMA Oncology|October 12, 2023
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled TrialYongwoo David Seo, Hailing Lu, Graeme Black, et al.
Nature Medicine|May 26, 2026
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trialPriscilla Merriam, James J Morrow, Emanuele Mazzola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B CellsPeter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022Margaret von Mehren, John M Kane, Richard F Riedel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, John M Kane, Mark Agulnik, et al.
Frontiers in Pharmacology|April 29, 2024
Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironmentKenneth R Gundle, Karthik Rajasekaran, Jeffrey Houlton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025Margaret von Mehren, John M Kane, Samantha A Armstrong, et al.
Lancet (London, England)|March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Cancer|May 3, 2017
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomasSeth M Pollack, Qianchuan He, Jennifer H Yearley, et al.
JAMA Oncology|October 12, 2023
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled TrialYongwoo David Seo, Hailing Lu, Graeme Black, et al.
Nature Medicine|May 26, 2026
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trialPriscilla Merriam, James J Morrow, Emanuele Mazzola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B CellsPeter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022Margaret von Mehren, John M Kane, Richard F Riedel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, John M Kane, Mark Agulnik, et al.
Frontiers in Pharmacology|April 29, 2024
Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironmentKenneth R Gundle, Karthik Rajasekaran, Jeffrey Houlton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025Margaret von Mehren, John M Kane, Samantha A Armstrong, et al.
Lancet (London, England)|March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.
Pageof 11